Project Grant HT94252410446
Award Date
7/1/24
Completion Date
6/30/28
Dollars Obligated
$927K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
This $602,550 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) supports adoptive cellular therapy research for pancreatic cancer. The awardee, the University of Nebraska Medical Center (UNMC), will conduct innovative biomedical research to develop novel therapeutic approaches, perform clinical trials, and provide technical expertise in this critical medical field. As a prominent academic research...
The Defense Health Agency awarded a $183,220 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "Targeting the CCL17/CCR4 Axis to Eradicate Lung Cancer Brain Metastasis," supports research focused on developing innovative approaches to treat lung cancer brain metastasis. The research conducted under this grant will investigate the CCL17/CCR4 axis, a signaling...
This federal Project Grant award in the amount of $1,439,093.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of New Mexico Health Sciences Center (UNM HSC). The grant will support advancing clinical research on ovarian cancer over a performance period from June 1, 2024 to May 31, 2028. As part of this award, UNM HSC will leverage its expertise in cancer research, genomics, and clinical trials to conduct...
This federal Project Grant award, in the amount of $915,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award is intended to "IMPROVE TARGETED OVARIAN CANCER THERAPY USING THE NOVEL NOTCH PATHWAY INHIBITOR AURANOFIN" at the University of New Mexico Health Sciences Center (UNM HSC) over the period of July 1, 2024 to June 30, 2027. UNM HSC, a leading academic medical center and health sciences institution,...
The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The grant is funded through the Military Medical Research and Development program (CFDA 12.420) and aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for the battlefield. The University...
The Department of the Army Medical Command, through the Military Medical Research and Development federal grant program (CFDA 12.420), awarded a $556,200.00 project grant to the University of Nebraska Medical Center (UNMC) for "ADOPTIVE CELLULAR THERAPY FOR PANCREATIC CANCER". The award, with a period of performance from October 1, 2024 to September 30, 2027, will fund advanced biomedical research to develop innovative treatments for pancreatic cancer. UNMC, a prominent academic...
The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The three-year award beginning December 30, 2022 will fund research by the University of Nebraska Medical Center to investigate medical solutions for metastatic breast cancer through innovative...
The University of Oklahoma Health Sciences Center was awarded a $1,144,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant, awarded on May 1, 2025, will fund a research project focused on "DRUG-TARGETING ORP4 AS A PRECISION OVARIAN CANCER TARGET" over a performance period of 4 years until April 30, 2029. The research aims to explore innovative approaches to the prevention, diagnosis, and...